Medical Device Network on MSN
FDA greenlight for Roche’s Alzheimer’s disease test sparks care paradigm shift
The availability of a rule-in-rule-out test for Alzheimer’s disease in primary care settings is likely to drive efficiencies throughout the care continuum.
Physicians and laboratorians must work to reduce use of antiquated clinical laboratory tests. We selected 10 representative tests considered antiquated by most experts in the clinical laboratory ...
MOST text-books of clinical biochemistry are written chiefly from the biochemist's point of view, and differ little from text-books of biochemistry proper except that practical details are given of ...
Researchers have devised a cheap, non-invasive and specific means to monitor progesterone production in women. The new technique uses saliva and liquid chromatography-tandem mass spectrometry ...
Low cholesterol can reduce the risk of dementia, a new University of Bristol-led study with more than a million participants ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback